Monotherapy Immunosuppression in Pediatric Heart Transplant Recipients
Monotherapy immunosuppression with calcineurin inhibitors may be preferred in a subset of pediatric HT patients with evidence of over-immune suppression without conferring increased risk of rejection.
Authors
- K. Wujcik (ORCID: https://orcid.org/0009-0008-1950-6550)
- Chiu‐Yu Chen (ORCID: https://orcid.org/0000-0002-1636-9633)
- E. Profita (ORCID: https://orcid.org/0000-0003-1578-3346)
- L. Barkoff
- Daniel Bernstein (ORCID: https://orcid.org/0000-0001-7761-5853)
- Seth A. Hollander (ORCID: https://orcid.org/0000-0002-0818-3150)
- Donna Lee
- Joanne Lee (ORCID: https://orcid.org/0000-0002-8008-6910)
Institutions
- Lucile Packard Children's Hospital (US)
- Palo Alto University (US)
- Stanford University (US)
Publication Details
- Journal
- Pediatric Transplantation
- Published
- 2025-08-05
- DOI
- https://doi.org/10.1111/petr.70157
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00